Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
63,075.22 -47.84 (-0.08%) CMC Crypto 200
1,308.88 -56.25 (-4.12%)
Aurinia Pharmaceuticals Inc. (AUPH)
After hours:
- Zacks
How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
The average of price targets set by Wall Street analysts indicates a potential upside of 96.5% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Business Wire
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
ROCKVILLE, Md. & EDMONTON, Alberta, May 07, 2024--Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
- Insider Monkey
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript May 2, 2024 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Aurinia […]
